Theoretically, a stable complex such as AHK-Cu could help or restore copper balance in neurological conditions, but this is still a theoretical concept that needs much more research before using in clinical settings
Zepbound (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist that is FDA-approved along with increased physical activity and a reduced-calorie diet for chronic weight management in adults with a starting body mass index (BMI) of: 30 kg/m^2 or higher (obesity) 27 kg/m^2 or higher (overweight) with at least one weight-related condition such as high cholesterol, high blood pressure (hypertension), type 2 diabetes, heart disease, or obstructive sleep apnea
198 B22, a novel indolinone derivative, inhibits CTSC activity and has been reported to reduce both inflammation and cytokine levels, 199 highlighting CTSC as a potential therapeutic target for limiting disease progression in pancreatitis
ECC, enteroendocrine cells
BPC-157 is generally well-tolerated when prescribed and monitored by a licensed medical professional